Add like
Add dislike
Add to saved papers

[Over-expression of thioredoxin-interacting protein promotes apoptosis of MIN6 cells via activating p38MAPK pathway].

Objective To investigate the effect of thioredoxin interacting protein (TXNIP) over-expression on the apoptosis of MIN6 β-cells and the mechanism involved. Methods Lentivirus carrying TXNIP gene was used to infect MIN6 β-cells in logarithmic growth phase, and the infection efficiency was evaluated by fluorescence microscope and Western blotting. Then MIN6 β-cells were divided into three groups: control group, empty lentivirus vector (LV-GFP) group and TXNIP over-expression (LV-GFP-TXNIP) group. CCK-8 assay was used to detect cell proliferation. AnnexinV-FITC/PI double staining was utilized to measure the apoptosis of MIN6 cells. Western blotting was applied to detect the expressions of TXNIP protein, TRX, Bax, Bcl2, cleaved caspase-3 (c-caspase-3), p38 mitogen-activated protein kinase (p38MAPK), phospho-p38MAPK (p-p38MAPK) proteins in the MIN6 β-cells before and after treated with p38MAPK inhibitor SP169316. Results At 72 hours after the infection, the infection rate reached (87.10±2.30)% and (92.21±0.54)% in LV-GFP group and LV-GFP-TXNIP group, respectively, suggesting that lentivirus-mediated TXNIP over-expression was desirable. Compared with control group and LV-GFP group, the cell viability markedly decreased, and cell apoptosis, Bax/Bcl2 ratio, expression of c-caspased-3 and p38MAPK phosphorylation significantly increased in LV-GFP-TXNIP group. However, both the Bax/Bcl2 ratio and c-caspase-3 protein expression in LV-GFP-TXNIP group were obviously reduced after treated with p38MAPK inhibitor. Conclusion TXNIP over-expression might promote the apoptosis of MIN6 cells via activating the p38 MAPK pathway.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app